Strategic Global Advisors, LLC Novartis Ag Transaction History
Strategic Global Advisors, LLC
- $468 Million
- Q2 2024
A detailed history of Strategic Global Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 5,451 shares of NVS stock, worth $623,975. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,451
Previous 10,737
49.23%
Holding current value
$623,975
Previous $1.04 Million
44.12%
% of portfolio
0.12%
Previous 0.23%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.4 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.39 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$849 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$848 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$681 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $246B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...